China · Delayed Price · Currency is CNY GKHT Medical Technology Statistics
Total Valuation
SHE:301370 has a market cap or net worth of CNY 4.86 billion. The enterprise value is 5.66 billion.
| Market Cap | 4.86B |
| Enterprise Value | 5.66B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | May 29, 2025 |
Share Statistics
SHE:301370 has 466.96 million shares outstanding. The number of shares has increased by 3.24% in one year.
| Current Share Class | 466.96M |
| Shares Outstanding | 466.96M |
| Shares Change (YoY) | +3.24% |
| Shares Change (QoQ) | -17.69% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 19.00% |
| Float | 224.31M |
Valuation Ratios
The trailing PE ratio is 63.59.
| PE Ratio | 63.59 |
| Forward PE | n/a |
| PS Ratio | 0.71 |
| PB Ratio | 1.90 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | 20.61 |
| P/OCF Ratio | 12.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.88, with an EV/FCF ratio of 23.99.
| EV / Earnings | 72.23 |
| EV / Sales | 0.83 |
| EV / EBITDA | 20.88 |
| EV / EBIT | 26.49 |
| EV / FCF | 23.99 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.56 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 5.15 |
| Debt / FCF | 5.92 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.85% and return on invested capital (ROIC) is 4.82%.
| Return on Equity (ROE) | 2.85% |
| Return on Assets (ROA) | 2.07% |
| Return on Invested Capital (ROIC) | 4.82% |
| Return on Capital Employed (ROCE) | 7.75% |
| Weighted Average Cost of Capital (WACC) | 5.36% |
| Revenue Per Employee | 6.78M |
| Profits Per Employee | 77,957 |
| Employee Count | 1,005 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 2.30 |
Taxes
In the past 12 months, SHE:301370 has paid 30.05 million in taxes.
| Income Tax | 30.05M |
| Effective Tax Rate | 29.29% |
Stock Price Statistics
The stock price has increased by +7.32% in the last 52 weeks. The beta is 0.48, so SHE:301370's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +7.32% |
| 50-Day Moving Average | 10.80 |
| 200-Day Moving Average | 11.23 |
| Relative Strength Index (RSI) | 46.63 |
| Average Volume (20 Days) | 3,139,514 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301370 had revenue of CNY 6.82 billion and earned 78.35 million in profits. Earnings per share was 0.16.
| Revenue | 6.82B |
| Gross Profit | 725.54M |
| Operating Income | 213.65M |
| Pretax Income | 102.61M |
| Net Income | 78.35M |
| EBITDA | 269.39M |
| EBIT | 213.65M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 641.20 million in cash and 1.40 billion in debt, with a net cash position of -754.04 million or -1.61 per share.
| Cash & Cash Equivalents | 641.20M |
| Total Debt | 1.40B |
| Net Cash | -754.04M |
| Net Cash Per Share | -1.61 |
| Equity (Book Value) | 2.55B |
| Book Value Per Share | 6.05 |
| Working Capital | 1.90B |
Cash Flow
In the last 12 months, operating cash flow was 386.35 million and capital expenditures -150.47 million, giving a free cash flow of 235.88 million.
| Operating Cash Flow | 386.35M |
| Capital Expenditures | -150.47M |
| Depreciation & Amortization | 55.75M |
| Net Borrowing | -296.73M |
| Free Cash Flow | 235.88M |
| FCF Per Share | 0.51 |
Margins
Gross margin is 10.64%, with operating and profit margins of 3.13% and 1.15%.
| Gross Margin | 10.64% |
| Operating Margin | 3.13% |
| Pretax Margin | 1.51% |
| Profit Margin | 1.15% |
| EBITDA Margin | 3.95% |
| EBIT Margin | 3.13% |
| FCF Margin | 3.46% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 0.81%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 0.81% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 88.94% |
| Buyback Yield | -3.24% |
| Shareholder Yield | -2.43% |
| Earnings Yield | 1.61% |
| FCF Yield | 4.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |